Myocardiopericarditis in adult Still's disease

Authors

  • Manuel Horna Servicio de Cardiología. Clinica Delgado
  • Rubén Romero Servicio de Cardiología. Clinica Delgado
  • César Larrauri Servicio de Cardiología. Clinica Delgado
  • Fernando Córdova Servicio de Cardiología. Clinica Delgado
  • Jorge Martín Mispireta Servicio de Cardiología. Clinica Delgado
  • Jorge Alarcón Servicio de Reumatología. Clinica Delgado

DOI:

https://doi.org/10.47487/apcyccv.v1i3.65

Keywords:

Still disease, myocarditis, Pericarditis

Abstract

Cardiac involvement in Adult-onset Still’s Disease (AOSD) usually manifests as a pericardial disease, that has a benign course. The myocarditis is a rare complication with 7% of prevalence. The diagnosis of AOSD is based in the Yamaguchi or Fautrel criteria. The treatment with steroids, metrotexate is the first and second therapeutic lines, respectively, the combination is effective in 70% of cases. We report one case of AOSD with unusual presentation of double cardiac commitment, Myopericarditis.

Downloads

Download data is not yet available.

References

Giacomelli R, Ruscitti P, Shoenfeld Y. A comprehensive review on adult onset Still’s disease. J Autoimmun 2018; 93: 24-36. doi: 10.1016/j.jaut.2018.07.018

Still GF. On a form of chronic joint disease in children. Med Chir Trans 1897; 80: 47-60. PMID: 20896907

Bywaters EG. Still’s disease in the adult. Ann Rheum Dis 1971; 30(2):121-133. doi: 10.1136/ard.30.2.121

Fautrel B, Zing E, Golmard JL, et al. Proposal for new set of classification criteria for adult-onset still disease. Medicine (Baltimore). 2002;81: 194-200. doi: 10.1097/00005792-200205000-00003.

Feist E, Mitrovic S, Fautrel B. Mechanism, biomarkers and targets for adult-onset Still’s disease. Nature Reviews Rheumatology. 2018; 14: 603-618. doi.org/10.1038/s41584-018-0081-x

Castañeda S, et al. Adult-onset Still’s disease: advances in the treatment. Best Practice & Research Clinical Rheumatology 2016; 30: 222-238. doi: 10.1016/j.berh.2016.08.003

Yamaguchi M, Ohta A, Tsunematsu T, et al. Preliminary criteria for classification of adult Still’s disease. J Rheumatol. 1992; 19: 424-30. PMID: 1578458

Gerfaud-Valentin M, Maucort-Boulch D, Hot A, et al. Adult-onset Still disease: manifestations, treatments, outcome, and prognostic factors in 57 patients. Medicine (Baltimore). 2014;93:91-99. doi: 10.1097/MD.0000000000000021

Gerfaud-Valentin M, Seve P, Jean I, et al. Myocarditis in adult-onset Still’s disease. Medicine 2014; 93: 280-289. doi: 10.1097/MD.0000000000000112

Smith SC, Ladenson JH, Mason JW et al. Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. Circulation. 1997; 95(1): 163–168. doi.org/10.1161/01.CIR.95.1.163

Friedrich MG, Sechtem U, Schulz-Menger J, et al. International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis (2009) Cardiovascular magnetic resonance in myocarditis: a JACC White Paper. J Am Coll Cardiol 53(17):1475–1487. doi: 10.1016/j.jacc.2009.02.007

Manger B, Rech J, Schett G. Use of methotrexate in adult-onset Still’s disease. Clin Exp Rheumatol 2010, 28: S168-171.

Magnani JW, Danik JH, Dec GW, et al. Survival in Biopsy-proven myocarditis; a long-term prospective analysis of histopathologic, clinical and hemodynamic predictors. Am Heart J. 2006 Feb; 151(2): 463-70. doi: 10.1016/j.ahj.2005.03.037.

Siddiqui M, Putman M, et al., Adult-onset Still´s disease: current challenges and future prospects. Rheumatology: Research and Reviews.2016(8),17-22.

Downloads

Published

2020-09-15

Issue

Section

Case reports